Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar 16;14(3):e241159.
doi: 10.1136/bcr-2020-241159.

Isolated deafness as a presenting symptom in granulomatosis with polyangiitis

Affiliations
Case Reports

Isolated deafness as a presenting symptom in granulomatosis with polyangiitis

Amy Kousha et al. BMJ Case Rep. .

Abstract

Granulomatosis with polyangiitis (GPA) is a rare small vessel vasculitis commonly affecting the lungs, upper respiratory tract and kidneys. It is an idiopathic condition but likely due to an autoimmune process, resulting in granulomatous lesions and glomerulonephritis. Upper respiratory tract involvement is commonly seen in patients with GPA. Our case is that of an elderly lady (Mrs C) presenting with sudden onset bilateral deafness. She was later found to have extensive lower respiratory tract involvement although she was never particularly symptomatic of this. The presentation suggested a single organ disorder and led to some initial diagnostic uncertainty. Imaging and laboratory investigations eventually led to the diagnosis and she was successfully treated with corticosteroids and rituximab with good response and hearing improvement. This case highlights the importance of early diagnosis in a rapidly progressive disease which undetected can lead to catastrophic end organ damage and disability.

Keywords: ear; nose and throat/otolaryngology; vasculitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Admission chest X-ray indicating multiple pulmonary opacities.
Figure 2
Figure 2
Pretreatment CT chest with contrast illustrating multiple cavitating masses in both lungs.
Figure 3
Figure 3
CT chest with contrast 10 days post-treatment commencement. Note marked reduction in size and number of lesions.
Figure 4
Figure 4
Follow-up chest X-ray at 3 months showing normal lung fields.

References

    1. Greco A, Marinelli C, Fusconi M, et al. . Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol 2016;29:151–9. 10.1177/0394632015617063 - DOI - PMC - PubMed
    1. Fauci AS, Haynes BF, Katz P, et al. . Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76–85. 10.7326/0003-4819-98-1-76 - DOI - PubMed
    1. Flossmann O, Bacon P, de Groot K, et al. . Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283–92. 10.1136/ard.2005.051078 - DOI - PMC - PubMed
    1. Kim SH, Jung AR, Kim SI, et al. . Refractory granulomatosis with polyangiitis presenting as facial paralysis and bilateral sudden deafness. J Audiol Otol 2016;20:55–8. 10.7874/jao.2016.20.1.55 - DOI - PMC - PubMed
    1. Masiak A, Zdrojewski Z, Pęksa R, et al. . The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia 2017;55:230–6. 10.5114/reum.2017.71638 - DOI - PMC - PubMed

Publication types

Supplementary concepts